Sprinklr Announces Third Quarter Fiscal 2026 Results

Go back to Sprinklr Announces Third Quarter Fiscal 2026 Results
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 4.97 +0.02 (0.40%)
Previous Close $4.95    52 Week High $1.44 
Open $5.05    52 Week Low $0.06 
Day High $5.09    P/E N/A 
Day Low $4.96    EPS $-1.24 
Volume 291,501